Blanchard D K, Rodloff A C, Steward W E, Hahn H, Friedman H
Infection. 1986 Nov-Dec;14(6):289-93. doi: 10.1007/BF01643965.
Previous reports have shown that Bacteroides fragilis may enhance the pathogenicity of coinfecting enterobacteriaceae by interfering with the host's immune response. With the present study, we have investigated the possible role of interferons (IFN) in mediating these effects. Mice injected with B. fragilis developed moderate serum levels of IFN that appeared just prior to alterations of the animals' immunity described earlier. The IFN was neutralized by treatment with anti-IFN-alpha/beta-antibodies or hydrochloric acid; hence it displayed the same "atypical" characteristics as IFN found in patients with immuno-compromising diseases such as AIDS, systemic lupus erythematosus or rheumatoid arthritis. Escherichia coli displayed the same induction patterns as B. fragilis, while gram-positive bacteria induced "regular" IFN alpha/beta and gamma. Spleen cells, peritoneal macrophages, or liver leukocytes taken from B. fragilis or E. coli-injected animals 6 h post infection were refractory to IFN induction by E. coli lipopolysaccharide in vitro; cells from mice infected with gram-positive organisms showed normal or enhanced responsiveness.
先前的报告表明,脆弱拟杆菌可能通过干扰宿主的免疫反应来增强共感染肠杆菌科细菌的致病性。在本研究中,我们调查了干扰素(IFN)在介导这些效应中可能发挥的作用。注射脆弱拟杆菌的小鼠血清中出现中等水平的干扰素,且恰好在上述动物免疫改变之前出现。该干扰素可通过用抗IFN-α/β抗体或盐酸处理而被中和;因此,它表现出与在艾滋病、系统性红斑狼疮或类风湿关节炎等免疫功能低下疾病患者中发现的干扰素相同的“非典型”特征。大肠杆菌表现出与脆弱拟杆菌相同的诱导模式,而革兰氏阳性菌诱导产生“常规”的IFN-α/β和γ。感染后6小时从注射脆弱拟杆菌或大肠杆菌的动物体内获取的脾细胞、腹腔巨噬细胞或肝白细胞,在体外对大肠杆菌脂多糖诱导的干扰素不敏感;感染革兰氏阳性菌的小鼠的细胞显示出正常或增强的反应性。